References
- Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020; 18: 2103–2109. https://doi.org/10.1111/jth.14975.
- Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S. et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020; 136: 489–500. Epub 2020/ 06/04. https://doi.org/10.1182/blood.2020006520
- Aggarwal M, Dass J, Mahapatra M. Hemostatic Abnormalities in COVID-19: an Update. Indian J Hematol Blood Transfusion. 2020; 36: 1–11. Epub 2020/ 08/25. https://doi.org/10.1007/s12288-020-01328-2.
- Gonzalez-Fajardo JA, Ansuategui M, Romero C, Comanges A, Gómez-Arbeláez D, Ibarra G, Garcia-Gutierrez A. Mortality of covid-19 patients with vascular thrombotic complications. Med Clin (Barc). 2021; 156: 112–117. Epub 2020/ 12/22. https://doi.org/10.1016/j.medcli.2020.10.004.
- Colling ME, Kanthi Y. COVID-19-associated coagulopathy: an exploration of mechanisms. Vascular Med (London, England). 2020; 25: 471–478. Epub 2020/ 06/20. https://doi.org/10.1177/1358863X20932640.
- Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflam Res Official J Eur Histamine Res Soc. 2020; 69: 1181–1189. Epub 2020/ 09/13. https://doi.org/10.1007/s00011-020-01401-6.
- Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment. Cardiovasc Drugs Ther. 2021; 35: 215–229. Epub 2020/ 10/20. https://doi.org/10.1007/s10557-020-07084-9.
- Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets. 2020; 31: 740–745. Epub 2020/ 05/28. https://doi.org/10.1080/09537104.2020.1768523.
- Lichtenberger LM, Vijayan KV. Is COVID-19–induced Platelet activation a cause of concern for patients with cancer? Cancer Res. 2021; 81: 1209–1211. https://doi.org/10.1158/0008-5472.CAN-20-3691.
- Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, CRR P, Righy C, Franco S, Souza TML, Kurtz P. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020; 136: 1330–1341. Epub 2020/ 07/18. https://doi.org/10.1182/blood.2020007252
- Levi M, Van Der Poll T, Schultz M. Systemic versus localized coagulation activation contributing to organ failure in critically ill patients. Semin Immunopathol. 2012; 34: 167–179. Epub 2011/ 08/02. https://doi.org/10.1007/s00281-011-0283-7.
- Parra-Izquierdo I, Aslan JE. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost. 2020; 46: 826–830. Epub 2020/ 09/04. https://doi.org/10.1055/s-0040-1715093
- Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, Smolenski A, Murphy C, Altaie H, Curran J. et al. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol. 2021; 19: e3001109. Epub 2021/ 02/18. https://doi.org/10.1371/journal.pbio.3001109
- Bongiovanni D, Klug M, Lazareva O, Weidlich S, Biasi M, Ursu S, Warth S, Buske C, Lukas M, Spinner CD. et al. SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype. Cell Death Dis. 2021; 12: 50. Epub 2021/ 01/09. https://doi.org/10.1038/s41419-020-03333-9
- Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J, Yang M. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020; 193: 110–115. Epub 2020/ 06/15. https://doi.org/10.1016/j.thromres.2020.06.008.
- Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? J Thromb Haemost. 2021; 19: 46–50. Epub 2020/ 10/30. https://doi.org/10.1111/jth.15156.
- Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M. et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020; 136: 1317–1329. Epub 2020/ 06/24. https://doi.org/10.1182/blood.2020007214
- Zakeri A, Jadhav AP, Sullenger BA, Nimjee SM. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerv Surg. 2021; 13: 202–206. Epub 2020/ 12/11. https://doi.org/10.1136/neurintsurg-2020-016794.
- Alnor A, Sandberg MB, Toftanes BE, Vinholt PJ. Platelet parameters and leukocyte morphology is altered in COVID-19 patients compared to non-COVID-19 patients with similar symptomatology. Scand J Clin Lab Invest. 2021; 81: 213–217. Epub 2021/ 03/10. https://doi.org/10.1080/00365513.2021.1894601.
- Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R. et al. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19. Circ Res. 2020; 127: 1404–1418. Epub 2020/ 09/18. https://doi.org/10.1161/CIRCRESAHA.120.317703
- Suess PM, Smith SA, Morrissey JH. Platelet polyphosphate induces fibroblast chemotaxis and myofibroblast differentiation. J Thromb Haemost. 2020; 18: 3043–3052. Epub 2020/ 08/19. https://doi.org/10.1111/jth.15066.
- Hashemieh M. Hematologic Parameters of COVID – 19: a review on alteration of hematologic laboratory findings. Int J Pediatr. 2020; 8: 11921–11929.
- Yasri S, Wiwanitkit V. Platelet count among the patients with novel coronavirus 2019 infection: an observation on 46 cases. J Re Med Sci. 2020; 25: 58. Epub 2020/ 10/23. https://doi.org/10.4103/jrms.JRMS_114_20.
- Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Comprehensive Clin Med. 2020; 1–11. Epub 2020/ 09/29. https://doi.org/10.1007/s42399-020-00521-8
- Metallidis S, Gioula G, Papaioannou M, Exindari M, Chrysanthidis T, Tsachouridou O, Mimtsoudis I, Christoforidi M, Zempekakis P, Papa-Konidari A. et al. Immune Thrombocytopenia in a Patient Recovering From COVID-19. HemaSphere. 2020; 4: e419. Epub 2020/ 11/03. https://doi.org/10.1097/HS9.0000000000000419
- Amgalan A, Othman M. Exploring possible mechanisms for COVID-19 induced thrombocytopenia: unanswered questions. J Thromb Haemost. 2020; 18: 1514–1516. Epub 2020/ 04/12. https://doi.org/10.1111/jth.14832.
- Lorenzo-Villalba N, Zulfiqar AA, Auburtin M, Schuhmacher MH, Meyer A, Maouche Y, Keller O, Andres E. Thrombocytopenia in the Course of COVID-19 Infection. Eur J Case Reports Internal Med. 2020; 7: 001702. Epub 2020/ 06/12.
- Wool GD, Miller JL. The Impact of COVID-19 disease on Platelets and coagulation. Pathobiology. 2021; 88: 15–27. Epub 2020/ 10/14. https://doi.org/10.1159/000512007.
- Deruelle E, Ben Hadj Salem O, Sep Hieng S, Pichereau C, Outin H, Jamme M. Immune thrombocytopenia in a patient with COVID-19. Int J Hematol. 2020; 112: 883–888. Epub 2020/ 07/18. https://doi.org/10.1007/s12185-020-02943-5.
- Chen W, Yang B, Li Z, Wang P, Chen Y, Zhou H. Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19. Lancet Haematol. 2020; 7: e624. Epub 2020/ 05/29. https://doi.org/10.1016/S2352-3026(20)30175-7.
- Battinelli EM. COVID-19 concerns aggregate around platelets. Blood. 2020; 136: 1221–1223. Epub 2020/ 09/22. https://doi.org/10.1182/blood.2020007805.
- Ulanowska M, Olas B. Modulation of hemostasis in COVID-19; blood Platelets may be important pieces in the COVID-19 puzzle. Pathogens. 2021 Mar; 10(3): 370. 1-11
- Denorme F, Manne BK, Portier I, Petrey AC, Middleton EA, Kile BT, Rondina MT, Campbell RA. COVID-19 patients exhibit reduced procoagulant platelet responses. J Thromb Haemost. 2020; 18: 3067–3073. Epub 2020/ 09/19. https://doi.org/10.1111/jth.15107.
- Althaus K, Marini I, Zlamal J, Pelzl L, Singh A, Häberle H, Mehrländer M, Hammer S, Schulze H, Bitzer M. et al. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 2021; 137: 1061–1071. Epub 2021/ 01/30. https://doi.org/10.1182/blood.2020008762
- Thushara RM, Hemshekhar M, Basappa KK, Rangappa KS, Girish KS, Girish KS. Biologicals, platelet apoptosis and human diseases: an outlook. Crit Rev Oncol Hematol. 2015; 93: 149–158. Epub 2014/ 12/03. https://doi.org/10.1016/j.critrevonc.2014.11.002.
- Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, Cerotto V, Guglielmini G, Gori F, Malvestiti M. et al. Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J Infect Dis. 2021; 223: 933–944. Epub 2020/ 12/07. https://doi.org/10.1093/infdis/jiaa756
- Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B. et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine. 2020; 24: 100434. Epub 2020/ 08/09. https://doi.org/10.1016/j.eclinm.2020.100434
- Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y. et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020; 13: 120. Epub 2020/ 09/06. https://doi.org/10.1186/s13045-020-00954-7
- Lumadue JA, Lanzkron SM, Kennedy SD, Kuhl DT, Kickler TS. Cytokine induction of platelet activation. Am J Clin Pathol. 1996; 106: 795–798. Epub 1996/ 12/01. https://doi.org/10.1093/ajcp/106.6.795.
- Maider Beitia,1, Diego Delgado,1, Pello Sánchez,1 Ana Vallejo de la Cueva,2,3 José Ramón Cugat,4 and Mikel Sánchez1,. Platelet lysate nebulization protocol for the treatment of COVID-19 and ITS sequels: proof of concept and scientific rationale. Int J Mol Sci. 2021; 224: 1856. Epub 2021/ 03/07. https://doi.org/10.3390/ijms22041856.
- Biswas I, Khan GA. Coagulation Disorders in COVID-19: role of Toll-like Receptors. J Inflamm Res. 2020; 13: 823–828. Epub 2020/ 11/06. https://doi.org/10.2147/JIR.S271768.
- Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, Neil D, Hoefer IE, Fragiadaki M, Waltenberger J. et al. Endothelial dysfunction in COVID-19: a position paper of the ESC working group for atherosclerosis and vascular biology, and the ESC council of basic cardiovascular science. Cardiovasc Res. 2020; 116: 2177–2184. Epub 2020/ 08/05. https://doi.org/10.1093/cvr/cvaa230
- Siddiqui SN, Jayasekhar R, Tshering S, Jugjali R, Shanmugavadivel D, Jawed A, Rahman MM. A unique tale of COVID-19 induced concomitant overt disseminated intravascular coagulation and acute bilateral pulmonary embolism. Int J Infect Dis. 2021; 104: 568–571. Epub 2021/ 01/25. https://doi.org/10.1016/j.ijid.2021.01.040.
- Salamanna F, Maglio M, Landini MP, Fini M. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Platelets. 2020; 31: 627–632. Epub 2020/ 05/14. https://doi.org/10.1080/09537104.2020.1762852.
- Chow JH, Khanna AK, Kethireddy S, Yamane D, Levine A, Jackson AM, McCurdy MT, Tabatabai A, Kumar G, Park P. et al. Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019. Anesth Analg. 2021; 132: 930–941. Epub 2020/ 10/24. https://doi.org/10.1213/ANE.0000000000005292
- Zaid Y, Guessous F, Puhm F, Elhamdani W, Chentoufi L, Morris AC, Cheikh A, Jalali F, Boilard E, Flamand L. Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19. Blood Adv. 2021; 5: 635–639. Epub 2021/ 02/10. https://doi.org/10.1182/bloodadvances.2020003513.
- Djakpo DK, Wang Z, Zhang R, Chen X, Chen P, Antoine M. Blood routine test in mild and common 2019 coronavirus (COVID-19) patients. Biosci Rep. 2020; 40: Epub 2020/ 07/30. https://doi.org/10.1042/BSR20200817.
- Kazancioglu S, Bastug A, Ozbay BO, Kemirtlek N, Bodur H. The role of haematological parameters in patients with COVID-19 and influenza virus infection. Epidemiol Infect. 2020; 148: e272. Epub 2020/ 11/06. https://doi.org/10.1017/S095026882000271X.
- Güçlü E, Kocayiğit H, Okan HD, Erkorkmaz U, Yürümez Y, Yaylacı S, Koroglu M, Uzun C, Karabay O. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras. 1992. 2020; 66: 1122–1127. Epub 2020/ 09/17. https://doi.org/10.1590/1806-9282.66.8.1122
- Bommenahalli Gowda S, Gosavi S, Ananda Rao A, Shastry S, Raj SC, Menon S, Suresh A, Sharma A. Prognosis of COVID-19: red cell distribution width, platelet distribution width, and C-reactive protein. Cureus. 2021; 13: e13078. Epub 2021/ 03/09.
- Althaus K, Marini I, Zlamal J, Pelzl L, Häberle H, Mehrländer M, Hammer S, Schulze H, Bitzer M, Malek N. et al. Severe COVID-19 infection is associated with increased antibody-mediated platelet apoptosis. Blood. 2021 Feb 25; 137(8): 1061–1071.
- O’Kennedy N, Duttaroy AK. Platelet hyperactivity in COVID-19: can the tomato extract Fruitflow® be used as an antiplatelet regime? Med Hypotheses. 2021; 147: 110480. Epub 2021/ 01/10. https://doi.org/10.1016/j.mehy.2020.110480.
- Canzano P, Brambilla M, Porro B, Cosentino N, Tortorici E, Vicini S, Poggio P, Cascella A, Pengo MF, Veglia F. et al. Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients. JACC Basic Translational Sc. 2021; 6: 202–218. Epub 2021/ 03/03.
- Choudry FA, Hamshere SM, Rathod KS, Akhtar MM, Archbold RA, Guttmann OP, Woldman S, Jain AK, Knight CJ, Baumbach A. et al. High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2020; 76: 1168–1176. Epub 2020/ 07/18. https://doi.org/10.1016/j.jacc.2020.07.022
- Sriram K, Insel PA. Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev. 2021; 101: 545–567. Epub 2020/ 10/31. https://doi.org/10.1152/physrev.00035.2020.
- Heinz C, Miesbach W, Herrmann E, Sonntagbauer M, Raimann FJ, Zacharowski K, Weber CF, Adam EH. Greater fibrinolysis resistance but no greater platelet aggregation in critically Ill COVID-19 patients. Anesthesiology. 2021; 134: 457–467. Epub 2021/ 01/09. https://doi.org/10.1097/ALN.0000000000003685.
- Nicolson PLR, Welsh JD, Chauhan A, Thomas MR, Kahn ML, Watson SP. A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors. Platelets. 2020; 31: 685–690. https://doi.org/10.1080/09537104.2020.1775189.
- Cooper N, Altomare I, Thomas MR, Nicolson PLR, Watson SP, Markovtsov V, Todd LK, Masuda E, Bussel JB. Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib. Ther Adv Hematol. 2021; 12: 20406207211010875. Epub 2021/ 05/18. https://doi.org/10.1177/20406207211010875.
- Godino C, Scotti A, Maugeri N, Mancini N, Fominskiy E, Margonato A, Landoni G. Antithrombotic therapy in patients with COVID-19? -Rationale and evidence. Int J Cardiol. 2021; 324: 261–266. Epub 2020/ 10/02. https://doi.org/10.1016/j.ijcard.2020.09.064.
- Wang Y, Ao G, Nasr B, Qi X. Effect of antiplatelet treatments on patients with COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2021; 43: 27–30. Epub 2021/ 01/24. https://doi.org/10.1016/j.ajem.2021.01.016.
- Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S. et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. 2021; 18: 194–209.